AMYLON THERAPEUTICS

amylon-therapeutics-logo

Amylon Therapeutics is a biotechnology company that uses RNA Modulation Technology to target rare genetic disorders of the central nervous system (CNS). Our mission is to deliver on the potential of our technology by developing life-changing therapeutic solutions for patients with serious unmet medical need. We have high ambitions and want to change the way the world looks at neurological disorders. The enormous burden these diseases put on patients and their loved ones is unacceptable and somet... hing we strive to change every day. We believe that every patient deserves the hope for a brighter future. Our vision is to build a sustainable drug development platform in which the whole is bigger than the sum of its parts. This will allow us to focus on CNS diseases large and small and hopefully leave no patient untreated.

#SimilarOrganizations #People #Financial #Website #More

AMYLON THERAPEUTICS

Social Links:

Industry:
Biotechnology Genetics Health Care Therapeutics

Founded:
2017-01-01

Address:
Leiden, Zuid-Holland, The Netherlands

Country:
The Netherlands

Website Url:
http://www.amylontx.com

Total Employee:
1+

Status:
Closed

Contact:
020-4044707

Email Addresses:
[email protected]

Total Funding:
300 K EUR

Technology used in webpage:
Domain Not Resolving Person Schema Gravatar Profiles Dutch Server Location


Similar Organizations

beren-therapeutics-logo

Beren Therapeutics

Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

spark-therapeutics-logo

Spark Therapeutics

Spark Therapeutics is focused on the development of gene therapy.

tmunity-therapeutics-logo

Tmunity Therapeutics

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells

tramontane-therapeutics-logo

Tramontane Therapeutics

Tramontane Therapeutics is a gene therapy company creates solutions for common neurological and metabolic illnesses.

Founder


thomas-de-vlaam_image

Thomas de Vlaam

Investors List

uniiq_image

UNIIQ

UNIIQ investment in Seed Round - Amylon Therapeutics

Official Site Inspections

http://www.amylontx.com

Unable to get host informations!!!

Loading ...

More informations about "Amylon Therapeutics"

Amylon Therapeutics - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 020-4044707 Amylon Therapeutics is a biotechnology company that uses RNA Modulation Technology to target rare genetic disorders โ€ฆSee details»

Amyl

Amyl Therapeutics is a preclinical-stage biotech company developing Pan-Amyloid Immunotherapy (PAI), a universal treatment for amyloid-mediated diseases.See details»

Pillar VC Team | Experienced Operators Supporting Scientists

Thomas wants to help founders bring new innovations to patients. Thomas has spent most of his career building biotech companies. Prior to Pillar VC, Thomas was at Flagship Pioneering, โ€ฆSee details»

Amylon Therapeutics - VentureRadar

Website: http://amylontx.com. Develops therapies for rare genetic central nervous system disorders, with a focus on Hereditary Cerebral Hemorrhage with Amyloidosis ...See details»

Amylon Therapeutics - Leiden, Netherlands - bionity.com

Nov 9, 2017 amylontx.com. Contact. Profile Products News. Contact. About Amylon Therapeutics. Amylon Therapeutics targets CNS disorders through an ultra-genetics โ€ฆSee details»

Amylon 2025 Company Profile: Valuation, Funding & Investors

Amylon General Information Description. Developer of a drug development platform designed for rare genetic disorders of the central nervous system. The company's platform is based on โ€ฆSee details»

Amylon Therapeutics B.V. - life-sciences-europe.com

Sep 12, 2017 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl โ€“ the European Association of Bioindustries; BioIndustry โ€ฆSee details»

Amylon Therapeutics BV - Drug pipelines, Patents, Clinical trials

Explore Amylon Therapeutics BV with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Nervous System Diseases, Technology Platform:Biological โ€ฆSee details»

Amylon Therapeutics | IT History Society

Amylon Therapeutics is a biotechnology company that targets CNS disorders through an ultra-genetics approach.Amylon Therapeutics is a biotechnology company that targets CNS โ€ฆSee details»

ProQR spins out CNS assets to form RNA rare disease biotech

Sep 13, 2017 ProQR has spun out its CNS assets to form Amylon Therapeutics. The offshoot starts life with seed funding and an RNA-based program targeting a rare genetic disease that โ€ฆSee details»

ProQR spins out Amylon Therapeutics as a privately-held company โ€ฆ

Key updates. ProQR spins out CNS-focused company, Amylon Therapeutics, with seed funding from a group of institutional and private investors. As part of the transaction, ProQR has โ€ฆSee details»

Amylon Therapeutics - VentureRadar

Similar Companies: Latus Bio USA Privately Held Latus Bio, Inc. is a biotechnology company focused on developing novel gene therapy candidates for central nervous system (CNS) โ€ฆSee details»

AT-01 (Amylon) - Drug Targets, Indications, Patents - Synapse

Active Organization-Inactive Organization. Amylon Therapeutics, Inc. Drug Highest Phase Pending Preclinical. First Approval Date-Regulation-Structure/Sequence. Boost your research โ€ฆSee details»

Amylon Therapeutics-ๅŠจ่„‰็ฝ‘ - vbdata.cn

[email protected] Amylon Therapeuticsๆ˜ฏไธ€ๅฎถ็”Ÿ็‰ฉๆŠ€ๆœฏๅ…ฌๅธ๏ผŒ้€š่ฟ‡่ถ…้—ไผ ๅญฆๆ–นๆณ•้’ˆๅฏนCNS็–พ็—…๏ผŒไธ“ๆณจไบŽ็ฝ•่ง็š„้—ไผ ็–พ็—…๏ผŒๅฏไฝœไธบๆ›ด้ข‘็นๅ‘็”Ÿ้€‚ๅบ”็—‡็š„ๅฏ่ƒฝ้€”ๅพ„ใ€‚ ไผไธš็”ปๅƒSee details»

Amylon Therapeutics B.V. - life-sciences-europe.com

Upcoming Events. ADLM 2024 Annual Meeting & Clinical Lab Expo Chicago (formerly AACC 2024) IMSC 2024 Melbourne; Pharmatech & Health East Africa 2024 with Medical & Lab East โ€ฆSee details»

News - Amyl

This occasion also marks an important leadership transition within our organization. We are delighted to introduce Damien Toulorge, our new Chief Scientific Officer(CSO). Damien brings โ€ฆSee details»

Andrew Brynes - Altruix Chief Financial Officer

Eric is leveraging the full power of the organizationโ€™s behavioral health expertise, growing physical presence, data, and innovative technology to unleash a pharmacy platform that improves โ€ฆSee details»

Reset

ResetSee details»

Amlogenyx - Crunchbase Company Profile & Funding

Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease. It is a spin-off from Ultragenyx Pharmaceutical.See details»

ALS Association, I AM ALS Call on Amylyx, FDA to Make Promising โ€ฆ

Dec 30, 2020 The phase 2 trial included 137 people with ALS across 25 medical centers that are part of the Northeast ALS (NEALS) continuum. People with ALS who received AMX0035 โ€ฆSee details»

linkstock.net © 2022. All rights reserved